_________
false
אורמד פארמסוטיקלס אינק
2
381
ORAMED PHARMACEUTICALS INC
Corporation no:
980376008
14166
Israel Securities Authority
Tel Aviv Stock Exchange
C003
(
Public
)
Reported via MAGNA:
24/01/2024
www.isa.gov.il
www.tase.co.il
Reference:
2024-02-007999
Time of broadcast:
00:08
00:08
Other Report or Announcement
Regulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
Form 8-K - HTIT JV Agreement
Form_8-K_-_January_23_2024_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
NASDAQ CM
Date of revision of form structure:
31/12/2023
Address:
Avenue of the Americas
01185
,
New York
10036
New York
,
USA
Tel:
844-9672633
,
02-5660001
Fax:
02-5660004
E-mail address:
office@oramed.com
Company site:
www.oramed.com
Previous names of reporting entity:
Name of the Signatory:
DEROVAN NETANEL MOSHE
Position of Signatory in the reporting corporation:
Chief Legal Officer & Secretary
Name of Employer Company:
Address:
Mamila
20
,
Jerusalem
9414904
Telephone:
02-5660001
Facsimile:
E-mail:
netanel@oramed.com
1
USA